SCHEMBL24535672

SCHEMBL24535672

COC(=O)c1cc(CNC(=O)OC(C)(C)C)n(C)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
KDM4A O75164 1/20 0.39
GFER P55789 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
ATR Q13535 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNA1B Q00975 1/20 0.36
CACNA1C Q13936 1/20 0.36
ALDH1A1 P00352 1/20 0.36
BRD4 O60885 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24537014 0.88 KDM4E (0.43) KDM4ELMNAKDM4AGFERL3MBTL1
SCHEMBL24535670 0.87 KDM4E (0.45) KDM4ELMNAKDM4AGFERL3MBTL1
SCHEMBL24537019 0.85 KDM4E (0.41) KDM4ELMNAKDM4AGFERL3MBTL1
SCHEMBL25407400 0.78 MAPK14 (0.46) LMNAMAPK1ATRMAPK14MMP2
SCHEMBL30752548 0.78 BRD4 (0.39) GFERALDH1A1BRD4DRD2
SCHEMBL24213254 0.78 DRD2 (0.39) GFERALDH1A1BRD4DRD2
SCHEMBL15273846 0.77 HTR2C (0.40) CACNA1BCACNA1CMMP2MMP13MMP14
SCHEMBL22084224 0.77 GFER (0.42) KDM4ELMNAKDM4AGFERL3MBTL1
SCHEMBL9197577 0.75 MMP2 (0.43) KDM4EHSD17B10POLBMAPK1ALDH1A1
SCHEMBL15771676 0.75 MMP2 (0.40) KDM4ELMNAHSD17B10MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735452-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN Merck Patent GmbH (DE) 2026-05-06 EP disclosed
WO-2025006753-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN MERCK PATENT GMBH (DE) 2025-01-02 WO disclosed
EP-4262807-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-10-25 EP disclosed
CN-116829151-A Azaquinazoline pan KRAS inhibitors 米拉蒂治疗股份有限公司 2023-09-29 CN disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 WO disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 WO disclosed